Noucor acquires HELM Pharmaceuticals
Finished drug products, development and manufacturing · Hamburg, Germanyacquired byNoucorPlatform ofMCH Private Equity
advised by
- Sell-side
- Jefferies(M&A)Freshfields(Recht)
- Buy-side
- Société Générale(M&A)PwC(M&A)Gleiss Lutz(Recht)
Noucor, a Spanish pharmaceutical company backed by MCH Private Equity, acquires HELM Pharmaceuticals, the German finished drug products business of HELM based in Hamburg. The company develops, produces and distributes medicines.
- Buyer
- Noucor
- Target
- HELM Pharmaceuticals, Hamburg
- Seller
- HELM
- Investor
- MCH Private Equity
- Type
- Add-on
- Sector
- Healthcare & Medtech
- Country
- Germany
- First reported
- 05/10/2026
- Sell-side
- Jefferies, Freshfields, according to the source
- Buy-side
- Société Générale, PwC, Gleiss Lutz, according to the source
- Source
- Freshfields
Deal-Radar no. 42-065 · added in Week 42/2026, first reported on 05/10/2026 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by MCH Private Equity
MCH Private Equity profileSo far this is the only transaction by MCH Private Equity published in the Deal-Radar. New deals are added every Monday.
Add-ons in Week 42/2026
All deals in October 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 19 October 2026.